Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (3) Bunse, Mario Dr. (3) Chen, Wei Prof. Dr. (2) Daumke, Oliver Prof. Dr. (2) Dittmar, Gunnar Dr. (1) Edes, Inan Dr. (1) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (2) Janz, Martin Dr. (5) Kammertöns, Thomas Dr. (3) Kärgel, Eva Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Klußmann, Enno PD Dr. (1) Ku, Min-Chi Dr. (1) Landthaler, Markus Prof. Dr. (2) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Obermayer, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rhein, Simone Dr. (1) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (11) Uckert, Wolfgang Prof. Dr. (19) Waiczies, Helmar Dr. (1) Waiczies, Sonia Dr. (1) Wanker, Erich Prof. Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Susanne Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Leisegang, Matthias Dr. (2) (-) Mathas, Stephan Dr. (7) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) (-) 2004 (2) 2005 (2) 2006 (5) (-) 2007 (3) 2008 (5) 2009 (3) 2010 (7) 2011 (5) 2012 (4) 2013 (1) 2014 (4) 2015 (8) (-) 2016 (4) 2017 (5) 2018 (1) 2019 (2) 2020 (2) 2021 (3) 2022 (4) (-) Biology of Malignant Lymphomas (7) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (2) Molecular Immunology and Gene Therapy (1) Signal Transduction in Tumor Cells (1) 9 Results: Active Filter: Leisegang, Matthias Dr.Mathas, Stephan Dr.Biology of Malignant LymphomasMolecular Cell Biology and Gene Therapy200420072016 Sort: Result score Newest to oldest Oldest to newest July 01, 2016 in Semin Hematol Hodgkin lymphoma: pathology and biology S. Mathas S. Hartmann R. Küppers June 01, 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber March 17, 2016 in Genome Med A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses K.A.P. de Oliveira E. Kaergel M. Heinig J.F. Fontaine G. Patone E.M. Muro S. Mathas M. Hummel M.A. Andrade-Navarro N. Hübner C. Scheidereit March 01, 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein October 01, 2007 in Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas May 01, 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas March 01, 2007 in Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto April 19, 2004 in J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken January 01, 2004 in Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken
July 01, 2016 in Semin Hematol Hodgkin lymphoma: pathology and biology S. Mathas S. Hartmann R. Küppers
June 01, 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber
March 17, 2016 in Genome Med A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses K.A.P. de Oliveira E. Kaergel M. Heinig J.F. Fontaine G. Patone E.M. Muro S. Mathas M. Hummel M.A. Andrade-Navarro N. Hübner C. Scheidereit
March 01, 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
October 01, 2007 in Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
May 01, 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
March 01, 2007 in Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
April 19, 2004 in J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
January 01, 2004 in Blood Jagged1-induced notch signaling drives proliferation of multiple myeloma cells F. Jundt K. Schulze-Proebsting I. Anagnostopoulos G. Muehlinghaus M. Chatterjee S. Mathas R.C. Bargou R. Manz H. Stein B. Doerken
